Albumin Market by Source (Animal Sources, Plant Sources), Type (Non-Recombinant, Recombinant), Application, End User - Global Forecast 2024-2030
360iResearch Analyst
Want to know more about the albumin market or any specific requirement? Ketan helps you find what you're looking for.
This free PDF includes market data points, ranging from trend analysis to market estimates & forecasts. See for yourself.

[186 Pages Report] The Albumin Market size was estimated at USD 6.53 billion in 2023 and expected to reach USD 6.94 billion in 2024, at a CAGR 6.61% to reach USD 10.23 billion by 2030.

Albumin is a complex and versatile protein that constitutes approximately 50%-60% of the total protein content in human blood plasma. It is synthesized predominantly by the liver and plays an essential role in physiological functions, such as maintaining osmotic pressure, binding and transporting various molecules, and acting as an antioxidant. Albumin's importance lies in its multifaceted contributions to overall health and well-being, making it a significant biomarker for assessing an individual's disease risk and clinical status. The growing usage of albumin in clinical settings for the treatment of burns and the rising prevalence of liver diseases where patients require a regular supply of HSA to maintain proper health functions has accelerated the use of albumin worldwide. However, risks associated with contamination and transmission of infectious agents in HSA products sourced from pooled human plasma donations impact albumin usage. Stringent regulatory guidelines for product approvals in different regions also affect the commercialization of albumin. Market players are investing in research and development initiatives that explore innovative production methods, such as plant-based expression systems or microbial fermentation processes capable of yielding high-quality albumin products at lower costs. New opportunities are emerging with the evolution of biotechnological advancements that enable the production of recombinant human albumins (rHA) through genetic engineering techniques.

Regional Insights

The Americas albumin market is advancing, driven by investments by pharmaceutical companies investing heavily in research and technology to develop advanced albumin formulations. Regulatory bodies such as the Food and Drug Administration (FDA) in the U.S. enforce strict quality control measures to assure safety standards of albumin. The FDA has also given approval for certain albumin products in recent years. Technological advancements such as recombinant HSA production are being researched across the U.S. and Canada to potentially reduce dependency on human plasma donations for albumin supply. The Asian albumin market is experiencing rapid expansion fueled by increasing healthcare expenditure and improving medical infrastructure in emerging countries demanding plasma-derived products for therapeutic purposes, including liver disease treatment, surgeries, and intensive care support. Europe is a potential contributor to the global albumin market, with an established consumption base and robust manufacturing capabilities. The use of albumin in Europe is primarily focused on critical care applications such as sepsis management, volume replacement therapies, and therapeutic plasma exchange procedures. The European Medicines Agency (EMA) regulates the production and distribution of albumin within the European Union (EU).

Albumin Market
To learn more about this report, request a free PDF copy
Market Dynamics

The market dynamics represent an ever-changing landscape of the Albumin Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

  • Market Drivers
    • Incidence of chronic diseases and use of albumin as a predictor of postoperative surgical site infections
    • Surging utilization of albumin as a food and cosmetic ingredient
  • Market Restraints
    • Potential of albumin to cause transmission of infections
  • Market Opportunities
    • Ongoing research activities regarding albumin nanoparticles
    • Advancements in albumin production and purification methods
  • Market Challenges
    • Stringent regulations associated with albumin manufacturing and quality control
Market Segmentation Analysis
  • Source: Consumer shift toward the plant-based albumins due to enhanced sustainability for specific therapeutic purposes.

    Albumin, an important protein in the blood, plays essential role in maintaining fluid balance and transporting hormones, fatty acids, and drugs. The two primary albumin sources are animal-based and plant-based. Animal-derived albumin is obtained from bovine serum (BSA), human plasma (HSA), and ovalbumin. Bovine serum albumin (BSA) is a vital ingredient in various applications, such as diagnostic reagents, vaccines, and cell culture media. BSA is widely utilized in diagnostics and research due to its affordability and accessibility. Human serum albumin (HSA) is preferred for certain clinical situations, such as drug delivery systems or volume expansion therapies, due to its biocompatibility with humans. HSA is used in medical emergencies such as burns treatment and cardiopulmonary bypass surgery. In recent years, plant-based alternatives have emerged as a sustainable option for albumin production due to their reduced environmental impact and potential allergen risks. Plant-derived albumins, including rice and soy protein, are gaining popularity as alternatives to animal-derived counterparts for applications in food & beverage production, pharmaceuticals, and cosmetics. Comparatively, animal-derived albumins have established medical applications, although they pose a risk of disease transmission. In contrast, plant-based albumins offer sustainability with minimal contamination risk but may lack compatibility for specific therapeutic purposes. However, consumer trends to preferences to choose products between animal or plant-based albumins depend on factors such as application purpose, purity requirements, sustainability concerns, and potential risks associated with animal proteins.

  • Type: Enhanced emphasis on the research and development of recombinant albumin as a synthetic protein to promote recombinant DNA technology

    Non-recombinant albumin is derived from natural sources, primarily human and bovine serum. It is widely used in pharmaceutical formulations, diagnostics, cell culture media, and medical devices due to its stabilizing properties for proteins and enzymes. The need-based preference for non-recombinant albumin arises from its availability in large quantities as a byproduct of blood fractionation processes. Recombinant albumin is produced using genetically engineered expression systems such as yeast and mammalian cells. It eliminates the risk of contamination with pathogens and offers a more consistent and sustainable supply compared to non-recombinant albumin. Recombinant albumin is mainly used in drug delivery systems, vaccines, cell therapy applications, and regenerative medicine. The preference for recombinant albumin is driven by its safety profile, as it is free from human or animal-derived components which may carry potential risks of transmitting infectious agents.

  • Application: Rising focus on vaccine manufacturing and drug delivery applications

    Albumin is widely used as a cosmetic ingredient due to its excellent water-binding properties, enhancing skin hydration and elasticity. In the biotechnology industry, albumin serves as an essential component of culture media to support cell growth and proliferation. Albumin's drug delivery application capitalizes on its ability to bind various molecules while maintaining stability in different conditions. Albumin is employed in various products as a food ingredient due to its functional properties, such as emulsification and foaming. Albumin-based therapeutics are employed in treatments for conditions such as hypoalbuminemia and burns. Moreover, vaccine manufacturers use albumins as stabilizers or preservatives to enhance vaccine stability during storage and transportation.

  • End-User: Extensive end-users of the albumin in hospitals and blood banks

    The major end-users of albumin can be categorized into primary sectors including, hospitals & clinics, pharmaceutical & biotechnology companies, academic research institutes, and blood banks. These establishments utilize albumin products for various purposes such as drug formulation, diagnostics, vaccine manufacturing, clinical nutrition support, cell culture growth media supplementation, and blood volume expansion. In hospitals & clinics Albumin is often employed to treat patients suffering from hypoalbuminemia – a condition characterized by low levels of albumin in the blood – caused by critical illness or injury. Additionally, it is utilized for fluid resuscitation during surgeries or trauma cases where blood loss has occurred. In recent years, albumin has also gained popularity as a component of parenteral nutrition formulas providing essential proteins needed for patients who are unable to consume food orally. Moreover, blood banks utilize it as a plasma expander to increase blood volume in patients undergoing blood transfusion or those with severe blood loss due to trauma, surgery, or other conditions. Albumin solutions can help maintain osmotic pressure, stabilize hemodynamic parameters, and improve overall circulatory function during such critical situations.

Market Disruption Analysis

The market disruption analysis delves into the core elements associated with market-influencing changes, including breakthrough technological advancements that introduce novel features, integration capabilities, regulatory shifts that could drive or restrain market growth, and the emergence of innovative market players challenging traditional paradigms. This analysis facilitates a competitive advantage by preparing players in the Albumin Market to pre-emptively adapt to these market-influencing changes, enhances risk management by early identification of threats, informs calculated investment decisions, and drives innovation toward areas with the highest demand in the Albumin Market.

Porter’s Five Forces Analysis

The porter's five forces analysis offers a simple and powerful tool for understanding, identifying, and analyzing the position, situation, and power of the businesses in the Albumin Market. This model is helpful for companies to understand the strength of their current competitive position and the position they are considering repositioning into. With a clear understanding of where power lies, businesses can take advantage of a situation of strength, improve weaknesses, and avoid taking wrong steps. The tool identifies whether new products, services, or companies have the potential to be profitable. In addition, it can be very informative when used to understand the balance of power in exceptional use cases.

Value Chain & Critical Path Analysis

The value chain of the Albumin Market encompasses all intermediate value addition activities, including raw materials used, product inception, and final delivery, aiding in identifying competitive advantages and improvement areas. Critical path analysis of the <> market identifies task sequences crucial for timely project completion, aiding resource allocation and bottleneck identification. Value chain and critical path analysis methods optimize efficiency, improve quality, enhance competitiveness, and increase profitability. Value chain analysis targets production inefficiencies, and critical path analysis ensures project timeliness. These analyses facilitate businesses in making informed decisions, responding to market demands swiftly, and achieving sustainable growth by optimizing operations and maximizing resource utilization.

Pricing Analysis

The pricing analysis comprehensively evaluates how a product or service is priced within the Albumin Market. This evaluation encompasses various factors that impact the price of a product, including production costs, competition, demand, customer value perception, and changing margins. An essential aspect of this analysis is understanding price elasticity, which measures how sensitive the market for a product is to its price change. It provides insight into competitive pricing strategies, enabling businesses to position their products advantageously in the Albumin Market.

Technology Analysis

The technology analysis involves evaluating the current and emerging technologies relevant to a specific industry or market. This analysis includes breakthrough trends across the value chain that directly define the future course of long-term profitability and overall advancement in the Albumin Market.

Patent Analysis

The patent analysis involves evaluating patent filing trends, assessing patent ownership, analyzing the legal status and compliance, and collecting competitive intelligence from patents within the Albumin Market and its parent industry. Analyzing the ownership of patents, assessing their legal status, and interpreting the patents to gather insights into competitors' technology strategies assist businesses in strategizing and optimizing product positioning and investment decisions.

Trade Analysis

The trade analysis of the Albumin Market explores the complex interplay of import and export activities, emphasizing the critical role played by key trading nations. This analysis identifies geographical discrepancies in trade flows, offering a deep insight into regional disparities to identify geographic areas suitable for market expansion. A detailed analysis of the regulatory landscape focuses on tariffs, taxes, and customs procedures that significantly determine international trade flows. This analysis is crucial for understanding the overarching legal framework that businesses must navigate.

Regulatory Framework Analysis

The regulatory framework analysis for the Albumin Market is essential for ensuring legal compliance, managing risks, shaping business strategies, fostering innovation, protecting consumers, accessing markets, maintaining reputation, and managing stakeholder relations. Regulatory frameworks shape business strategies and expansion initiatives, guiding informed decision-making processes. Furthermore, this analysis uncovers avenues for innovation within existing regulations or by advocating for regulatory changes to foster innovation.

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Albumin Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Albumin Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments
  • Grifols Completes Enrollment In Phase 3 Study Of Long-Term Albutein (Albumin-Human Injection) Therapy For Patients With Decompensated Cirrhosis

    Grifols SA has completed enrollment in the PRECIOSA Phase 3 trial, which aims to evaluate the potential of long-term albumin treatment with Albutein in increasing the survival time of patients with decompensated cirrhosis and ascites. Albumin exhibits antioxidant and anti-inflammatory properties that could help alleviate complications associated with decompensated cirrhosis, ultimately reducing mortality rates for this condition. [Published On: 2023-07-18]

  • Kedrion's Global Portfolio Expands To China To Supply Human Albumin

    Kedrion Biopharma, an international biopharmaceutical company, announced the approval of its human Albumin product for release in the Chinese market. This approval is a significant milestone for the company, as it marks the first-ever biopharmaceutical product to be approved in China. It enables Kedrion to regularly ship its products to the country, meeting the substantial demand from China. [Published On: 2023-07-12]

  • GC Biopharma inks USD 90mn deal for blood products in Brazil

    GC Biopharma Co. has entered into a five-year supply agreement with Blau Farmacêutica, a Brazilian pharmaceutical company, to provide its IVIG-SN 5% blood product, valued at USD 90.48 million. This partnership with Blau Farmacêutica represents a significant opportunity for GC Biopharma to expand its global market share and further contribute to the healthcare industry. [Published On: 2023-07-03]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Albumin Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Albumin Market, highlighting leading vendors and their innovative profiles. These include Aadi Bioscience, Inc., Agilent Technologies, Inc., Akron Biotech, Atlantis Bioscience Pte Ltd., Avantor Inc., Baxter International Inc., Becton, Dickinson and Company, Bio Products Laboratory Ltd., Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Biogenix Inc. Pvt. Ltd., Biophyll GmbH, Biorbyt Ltd., Biowest SAS, Boston BioProducts Inc., Bristol-Myers Squibb Company, CENTURION PHARMA İlaç Sanayi ve Ticaret A.Ş., China Biologic Products Holdings, Inc. by Taibang Biologic Group, CSL Limited, Dem İlaç, F. Hoffmann-La Roche AG, GC Biopharma Corp., Glentham Life Sciences Limited, Grifols SA, InVitria, InVitroCare Inc., Kedrion S.p.A, Kraeber & Co. GmbH, Lazuline Biotech Private Limited, LGC Science Group Holdings Limited, Merck KGaA, Midas Pharma GmbH, Octapharma AG, Promega Corporation, Prospec-Tany Technogene Ltd., Rockland Immunochemicals Inc., Rocky Mountain Biologicals, LLC, Sartorius AG, Serion GmbH, SK Plasma, Takeda Pharmaceuticals Company Limited, Thermo Fisher Scientific Inc., Ventria Bioscience Inc., and VitroScient.

Albumin Market - Global Forecast 2024-2030
To learn more about this report, request a free PDF copy
Market Segmentation & Coverage

This research report categorizes the Albumin Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Source
    • Animal Sources
      • Bovine Serum Albumin
      • Human Serum Albumin
      • Ovalbumin
    • Plant Sources
  • Type
    • Non-Recombinant
    • Recombinant
  • Application
    • Cosmetic Ingredient
    • Culture Media
    • Drug Delivery
    • Food Ingredient
    • Therapeutic
    • Vaccine Ingredient
  • End User
    • Pharmaceutical & Biotechnology
    • Research Institutes

  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

This research report offers invaluable insights into various crucial aspects of the Albumin Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

Table of Contents
  1. Preface
  2. Research Methodology
  3. Executive Summary
  4. Market Overview
  5. Market Insights
  6. Albumin Market, by Source
  7. Albumin Market, by Type
  8. Albumin Market, by Application
  9. Albumin Market, by End User
  10. Americas Albumin Market
  11. Asia-Pacific Albumin Market
  12. Europe, Middle East & Africa Albumin Market
  13. Competitive Landscape
  14. Competitive Portfolio
  15. List of Figures [Total: 24]
  16. List of Tables [Total: 466]
  17. List of Companies Mentioned [Total: 44]
Albumin Unboxed: The Manifaceted Protein Transforming Industries
December 28, 2023
Albumin Unboxed: The Manifaceted Protein Transforming Industries
In a dynamic world where adaptability and versatility are highly valued, albumin, a protein produced by the liver and found in the blood, is proving indispensable and poised for continued growth and innovation.

Albumin, often flying under the radar, is a powerhouse protein that plays diverse roles in various sectors, not just within the realm of healthcare. Its primary role is to maintain the right balance of fluid within blood vessels, ensuring they don't get leaky.

Beyond its importance in healthcare emergencies such as burn treatments, hypovolemia, and ascites, albumin is becoming a star in diverse industries. Cosmetic and skincare products now feature albumin for its ability to rejuvenate skin and promote firmness. Furthermore, the world of biotechnology and pharmaceuticals is finding groundbreaking applications for albumin due to its unique properties.

A notable innovation is the development of recombinant albumin, which is created without using human sources. This is a game-changer, especially in the pharmaceutical and biotechnology sectors. It opens doors for the development of medicines, vaccines, and cell culture technologies.

In March 2023, Albumedix Ltd introduced Recombumin, an animal and human-origin-free recombinant albumin, as a critical component of Heartseed's HS-001, an investigational cardiac remuscularization cell therapy.

Recent innovations, including recombinant albumin, are revolutionizing its application, while the trend of using albumin in cosmetics and skincare demonstrates its adaptability. Whether in a hospital or a skincare product, albumin is no longer just an unsung hero – it's becoming a star.

The Surging Utilization of Albumin as a Food and Cosmetic Ingredient
October 19, 2023
The Surging Utilization of Albumin as a Food and Cosmetic Ingredient
As the world continues to evolve, so does the need to develop new and innovative products from natural resources. Albumin, a protein found in the blood, is one such resource that has gained popularity due to its versatility and numerous beneficial properties. Initially, albumin was mainly used in the healthcare industry to treat specific medical conditions. However, there has been a surge in its utilization as a food and cosmetic ingredient in recent years. This blog post explores the use of albumin in the food and cosmetic industry and its numerous benefits.

Albumin's Use in Food Production:

Albumin is a protein that is both water and fat-soluble, and this attribute makes it ideal for use in food production. It can be used as a binding agent in meat products and egg substitutes and as an ingredient in baking to improve dough texture and make cakes and pastries fluffier. Due to its high nutritional value, albumin is also used in sports drinks, protein bars, and other nutritional supplements. Its versatility allows food manufacturers to use it as a natural alternative to other binding and stabilizing agents, especially those that are derived from synthetic materials.

Albumin's Use in Cosmetic Production:

Albumin has many uses in the cosmetic industry, primarily as a skincare ingredient. Its unique attributes allow it to firm and tighten the skin, decreasing the appearance of fine lines and wrinkles and promoting a youthful look. It can also be used in hair-care products to improve hair texture, reduce frizz, and give hair that extra shine. Additionally, albumin's water-binding properties make it ideal for moisturizing products, ensuring the skin remains hydrated throughout the day.

Therapeutic Uses of Albumin in Medicine:

Albumin's therapeutic uses in medicine are not left out in this conversation. It is commonly used in critical care situations for patients with various medical conditions. These include septic shock, liver disease, burns, and many others. In addition, it is essential in stabilizing blood volume in the body due to its ability to bind with water molecules. This makes it a critical component in recovery from illnesses that cause a drop in blood volume, such as dehydration.

Albumin as a Source of Economic Growth:

Recently, albumin has become increasingly popular in China, Japan, and the USA. This surge in demand has been driven by the increase in the number of cosmetics and food manufacturers that use it as an ingredient. Albumin has emerged as a possible alternative to many synthetic agents, which have been scrutinized consistently by the regulatory bodies for potential side effects. With albumin being a naturally occurring protein, it poses few or no side effects, making it a sought-after ingredient in various industries.

Albumin's versatility has made it a highly sought-after protein, with its utilization expanding beyond the healthcare industry. The protein shows immense potential in the cosmetic and food industries, with benefits ranging from anti-aging properties to improved hair texture and skin hydration. With the surge in demand for locally sourced and natural ingredients, albumin has emerged as a solution, providing a sustainable alternative to many synthetic agents. As the world seeks new and innovative products, albumin is poised to become a key ingredient in many industries, providing sustainable and natural solutions.

Frequently Asked Questions
  1. How big is the Albumin Market?
    Ans. The Global Albumin Market size was estimated at USD 6.53 billion in 2023 and expected to reach USD 6.94 billion in 2024.
  2. What is the Albumin Market growth?
    Ans. The Global Albumin Market to grow USD 10.23 billion by 2030, at a CAGR of 6.61%
  3. When do I get the report?
    Ans. Most reports are fulfilled immediately. In some cases, it could take up to 2 business days.
  4. In what format does this report get delivered to me?
    Ans. We will send you an email with login credentials to access the report. You will also be able to download the pdf and excel.
  5. How long has 360iResearch been around?
    Ans. We are approaching our 7th anniversary in 2024!
  6. What if I have a question about your reports?
    Ans. Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available and included in every purchase to help our customers find the research they need-when they need it.
  7. Can I share this report with my team?
    Ans. Absolutely yes, with the purchase of additional user licenses.
  8. Can I use your research in my presentation?
    Ans. Absolutely yes, so long as the 360iResearch cited correctly.